Hydroxyurea for Ugandan Children with Sickle Cell Anemia. [PDF]
Green NS, Idro R, Bangirana P.
europepmc +1 more source
A liquid- and capsule-compatible hydroxyurea electronic monitor to identify non-adherent youth with sickle cell disease. [PDF]
Young A +9 more
europepmc +1 more source
Real-world treatment patterns, outcomes, and healthcare resource use for myelofibrosis in Brazil: Subgroup analysis of the METER study. [PDF]
Seguro F +3 more
europepmc +1 more source
Fixed Drug Reaction and Melanonychia from Hydroxyurea
Introduction. This case report presents a unique instance of a fixed drug eruption (FDE) and melanonychia linked to Hydroxyurea, a chemotherapeutic agent commonly used in the treatment of myeloproliferative disorders.
Suarez, Ana, Norman, Robert A.
core
Synchronous Coexistence of JAK2 V617F-Positive Essential Thrombocythemia and IgG Kappa Multiple Myeloma in an Octogenarian Patient: A Case Report. [PDF]
Ribero-Vargas M +3 more
europepmc +1 more source
Growth and puberty in African children with sickle cell anemia treated with hydroxyurea. [PDF]
Backeljauw P +10 more
europepmc +1 more source
Efficacy of curcumin and resveratrol in the synergistic activation of foetal haemoglobin in sickle cell disease. [PDF]
Kumar R, Mohapatra E.
europepmc +1 more source
Evaluation of hydroxyurea effect in patients with sickle cell disease: A prospective observational study. [PDF]
Battina A +8 more
europepmc +1 more source

